scholarly article | Q13442814 |
P50 | author | Akseli Hemminki | Q26920981 |
David T. Curiel | Q64384545 | ||
P2093 | author name string | Maaike Everts | |
Minghui Wang | |||
Ronald D Alvarez | |||
Ilya Ulasov | |||
Joanne T Douglas | |||
Dirk M Nettelbeck | |||
Martina Breidenbach | |||
Daniel T Rein | |||
Angel R Rivera | |||
P433 | issue | 5 | |
P921 | main subject | ovarian cancer | Q172341 |
Adenoviridae | Q193447 | ||
gene therapy | Q213901 | ||
cancer gene therapy | Q124350675 | ||
P304 | page(s) | 509-518 | |
P577 | publication date | 2004-05-01 | |
P1433 | published in | Human Gene Therapy | Q15757580 |
P1476 | title | Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy | |
P478 | volume | 15 |
Q34008026 | A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect |
Q37409025 | Adenoviral vector-based strategies for cancer therapy |
Q33994011 | Adenovirus receptors and their implications in gene delivery |
Q36468656 | Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism |
Q40308939 | An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution in mice |
Q34643252 | Chapter two--Adenovirus strategies for tissue-specific targeting |
Q39892766 | Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells |
Q24683229 | Current developments in adenovirus-based cancer gene therapy |
Q45878552 | Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX. |
Q35029126 | Directing systemic oncolytic viral delivery to tumors via carrier cells |
Q37482834 | Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity |
Q45865369 | Enhanced local delivery with reduced systemic toxicity: delivery, delivery, and delivery. |
Q40350503 | Infectivity enhancement for adenoviral transduction of canine osteosarcoma cells |
Q42189992 | Novel viral vectors utilizing intron splice-switching to activate genome rescue, expression and replication in targeted cells |
Q36318189 | Oncolytic adenoviruses - selective retargeting to tumor cells |
Q35414941 | Pathology, organ distribution, and immune response after single and repeated intravenous injection of rats with clinical-grade parvovirus H1 |
Q36315580 | Recent progress in the battle between oncolytic viruses and tumours |
Q38769919 | Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy. |
Q40381616 | Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. |
Q47148067 | Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-κB. |
Q35609035 | Transductional targeting of adenovirus vectors for gene therapy |
Search more.